Impact of Meditation on Improving Quality of Life Among Glaucoma Patients: A Study Protocol

The primary objective of this study is to assess the feasibility of administering an online meditation program compared to usual care to glaucoma patients to improve mental health outcomes such as quality of life, depression, anxiety, and sleep quality. The secondary objective of this study is to improve mental health outcomes among glaucoma patients.

This is a study protocol for a 12-week randomized control trial employing a mixed methods design. Glaucoma patients will be recruited from the Ivey Eye Institute in St. Joseph's Hospital Center. Eligible patients will include glaucoma patients of at least 75 years of age. Consented participants will be randomized to an online meditation group or usual care group in blocks of 4, or 2 per arm. Patients assigned to the online meditation group will undergo guided meditation sessions led by a meditation instructor via Microsoft Teams. Patients randomized to the usual care arm will undergo their usual glaucoma treatment. All study questionnaires including feasibility metrics, SF-12, CES-D, HADS-A and PSQI will be administered to both treatment groups at week 1, week 3, week 6, and week 12. Following study conclusion, feasibility metrics will be sent to participants in the intervention arm. In addition, patients randomized to the usual care arm will be given the opportunity to enroll in the meditation program after the 12 week study period, but no data will be collected.

To the best of the authors' knowledge, this study is the first of its kind to assess the feasibility of administering an online meditation intervention to glaucoma patients. If the findings from this study demonstrate positive results in favor of the treatment, this will be used to justify larger clinical trials and eventually, the integration of online meditation into the standard of care for glaucoma patients.